INOVEC – a research and InNOvation Partnership for enhancing the surveillance and control of mosquito VECtors of emerging arboviruses

INOVEC proposes the establishment of a cross-sectoral and multidisciplinary network to develop, optimise and promote integrated approaches and innovative tools for the surveillance and control of mosquito vectors of emerging arboviruses.
The project brings together 21 academic and non-academic institutions specialised in vector biology, social sciences and product development to stimulate research, strengthen capacities, promote career development and facilitate knowledge transfer.

Details

Status:

Supported by BayFOR:

Research Focus:

  • Medicine and Health

Project Coordination:

Institut Recherche pour le Développement
(IRD)

Other Partners:

Centre De Cooperation Internationale En Recherche Agronomique Pour Ledeveloppement - C.I.R.A.D. EPIC, France Centre National De La Recherche Scientifique CNRS, France Ecole Nationale Superieure Dd L'electronique et de ses Applications, France ENZYQUEST Private Company, Greece IDRYMA TECHNOLOGIAS KAI EREVNAS, Greece Universidade Nova De Lisboa, Portugal IRIDEON SL, Spain MAPA TECHNOLOGY S.L., Spain Agencia Estatal Consejo Superior de Investigaciones Cientificas, Spain Institut Louis Malarde, French Polynesia K&S HOLDING BV, Netherlands Fundacao Oswaldo Cruz, Brazil International Atomic Energy Agency, Austria Schweizerisches Tropen und Public Health Institut, Switzerland Universidade Estadual Paulista Julio De Mesquita Filho, Brazil Universite Grenoble Alpes, France The Chancellor, Masters And Scholars of The University of Oxford, United Kingdom Johns Hopkins University, United States Fondation Pour Un Centre Suisse De Recherches Scientifiques En Cote D'ivoire, Switzerland

Countries:

Germany (Bavaria), Madagascar, Sao Tome And Principe, Cote D’Ivoire, Mauritius, Burkina Faso, Tanzania, United Republic Of

Funding Agency:

European Union (EU)

Funding Type:

Horizon Europe (HEU)

Duration:

01/01/2023
31/12/2026

Budget:

1407600 EUR

URL: